Video Buzz v1

RelatedLinks

June 29th

• Bevacizumab Not Beneficial in Early Colon Cancer, CO-8 results: Don't use Bev as adjuvant Rx

June 23rd

• CancerMath.net

May 31st

• Medical News: ASCO: Targeted Therapy Misses the Mark in Early Colorectal Cancer - in Meeting Coverage, ASCO from MedPage Today: Bevacizumab (Avastin) did not demonstrate significant efficacy in early colorectal cancer - watch an embedded video of the experts discussion. Interesting.

May 27th

• Cancer Help And Advice: melanoma chemotherapy. side effects of chemotherapy: Breast chemotherapy refers to the treatment applied to patients who suffer from breast cancer. Its purpose is to kill or to reduce in size the tumor consisting of cells that multiply very quickly compared to the normal rate of multiplication of normal cells.

April 23rd

• Genentech: Newsroom: Press Releases: News Release April 21, 2009: "While we are disappointed the C-08 study did not meet its primary endpoint, our initial review of the data leads us to continue to believe Avastin may be active in patients with early-stage colon cancer and look forward to NSABP's presentation at ASCO," said Hal Barron, M.D., senior vice president, Development and chief medical officer, Genentech. "We remain fully committed to the ongoing Avastin adjuvant programs in early-stage colon, breast and lung cancers."
• Bevacizumab Study in Early-Stage Colon Cancer Misses Primary Endpoint - OncologySTAT: Genentech, Inc., announced today that the National Surgical Adjuvant Breast and Bowel Project (NSABP) C-08 study did not meet its primary endpoint of improved disease-free survival (DFS) with adjuvant use of bevacizumab (Avastin®) plus chemotherapy in patients with early-stage colon cancer. This was based on results from the final analysis of the NSABP C-08 study, a randomized multinational phase III study designed to evaluate the efficacy of adjuvant 5-fluorouracil , leucovorin, and oxaliplatin (FOLFOX), with or without bevacizumab, in patients with resected stage II or III adenocarcinoma of the colon. Bevacizumab is already approved by the US Food and Drug Administration for the treatment of metastatic colorectal cancer. This is the first phase III study of bevacizumab in early-stage disease.

April 13th

• Acacia Pharma - Acacia Pharma Ltd, Cambridge
• Competitor - Cisplatin - Wikipedia, the free encyclopedia - Paclitaxel adjuvant Taxol: Cisplatin is a platinum-based chemotherapy drug used to treat various types of cancers. It was the first member of its class, which now also includes carboplatin and oxaliplatin. Platinum complexes are formed in cells, which bind and cause crosslinking of DNA; ultimately triggering apoptosis(prog rammed cell death). Cisplatin combination chemotherapy is the cornerstone of treatment of many cancers. Initial platinum responsiveness is high but the majority of cancer patients will eventually relapse with cisplatin-resi stant disease. Many mechanisms of cisplatin resistance have been proposed including changes in cellular uptake and efflux of the drug, increased detoxification of the drug, inhibition of apoptosis and increased DNA repair. Oxaliplatin is active in highly cisplatin-resi stant cancer cells in the laboratory only to date. The drug Paclitaxel may be useful in the treatment of cisplatin-resi stant cancer; the mechanism for this activity is unknown.

March 13th

• F5506 Freund?s Adjuvant, Incomplete liquid

March 2nd

• Expert Reviews calling for better research on vaccine adjuvants

February 2nd

• Terapia adyuvante para el cáncer de seno: preguntas y respuestas: National Cancer Institute Factsheet: Adjuvant Therapy for Breast Cancer: Questions and Answers (Espanol)
• Adjuvant Therapy for Breast Cancer: Questions and Answers: National Cancer Institute Fact Sheet

November 17th

• Ligue Nationale Pour la Liberté des Vaccinations, Composants des vaccins

September 15th

• Adjuvant chemotherapy - Wikipedia

September 5th

• Untitled Page

RelatedImages

No Images Available!

Video Buzz > Adjuvant

Video Buzz Video Player :)

No Matching Video

No video for Adjuvant is available at this time.

Related Adjuvant News

No vaccine available­?yet - Manila Times

BECAUSE existing stocks ?are unlikely to meet the demand,? the World Health Organization is stocking up on antivirals and antibiotics. The goal this year is an eventual vaccine that is accessible and affordable, especially in poor countries ...

Canada-U.S. may go different routes on pandemic vaccine production - News1130.com

TORONTO - Canada and the United States may go separate ways when deciding whether powerful boosting compounds called adjuvants should be added to swine flu vaccines, experts suggest. Canada will likely use adjuvanted swine flu vaccine, says Dr. David ...

Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen ... - Earthtimes

BURLINGAME, Calif. - (Business Wire) Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, today announced the signing of a definitive agreement with Antigen Discovery, Inc. (ADi) to access ADi ...

Swine flu vaccine made in Europe - BBC Health

The first doses of an H1N1 swine flu vaccine have been produced in Europe - but it will be around two months before any is distributed. The doses were produced by Novartis at a plant in Marburg, Germany. The vaccine was made in cell culture, a much ...

Dr. N. Joseph Espat Presented Positive Clinical Results on the Use of ... - Genetic Engineering News

Dr. N. Joseph Espat M.D., M.S., FACS presented favorable results of biologic materials, specifically Cook Medical ?s Biodesign?, for the treatment of abdominal wall wounds complicated from chemotherapy, at the Abdominal Wall Reconstruction ...

Adjuvant Podcasts

Do you prefer to listen to your adjuvant gossip? Check out Podzy Podcast Directory > Adjuvant.

Adjuvant Products

Looking for adjuvant related products, then look no further. Try our new Adjuvant Shop.